Citation Impact
Citing Papers
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
2003 StandoutScienceNobel
Homeostatic maintenance of natural Foxp3 + CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization
2005 StandoutNobel
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
2019 StandoutNobel
CD4+ Tregs and immune control
2004 StandoutNobel
Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
2014
Re-establishing immunological self-tolerance in autoimmune disease
2012 StandoutNobel
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
2001 Standout
Inflammation and cancer
2002 StandoutNature
A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexate
1999 Standout
The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells
2006 Standout
Antimalarial drugs in the treatment of rheumatological diseases.
1997
Rheumatoid arthritis
2016 Standout
Population Pharmacokinetics of Hydroxychloroquine in Patients With Rheumatoid Arthritis
2003
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
2002 StandoutNature
Regulatory T Cells
2000 StandoutNobel
Photoprotective compounds from marine organisms
2010
Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial
2007
Regulatory T Cells and Immune Tolerance
2008 StandoutNobel
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
2009 Standout
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
1999 Standout
Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study
2006
Therapies for Active Rheumatoid Arthritis after Methotrexate Failure
2013
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial
2005
Tumor Necrosis Factor-α Blockade: A Novel Therapy for Rheumatic Disease
2002
Metalloproteases and inhibitors in arthritic diseases
2001
Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells
2010 Standout
Using the Acropora digitifera genome to understand coral responses to environmental change
2011 StandoutNature
Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self
2005 StandoutNobel
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
2009 StandoutNobel
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
2001 Standout
Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice
2003 StandoutNatureNobel
Superior efficacy of combination therapy for rheumatoid arthritis: Fact or fiction?
2005
Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial
2014
Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components
1999
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
2000 Standout
Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial
1999
Should imporvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent?
1998
Climate-driven trends in contemporary ocean productivity
2006 StandoutNature
Tetracyclines: Nonantibiotic properties and their clinical implications
2006
Regulatory T cells in transplantation tolerance
2003 StandoutNobel
The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
2005
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
2000 Standout
FOXP3+ regulatory T cells in the human immune system
2010 StandoutNobel
Treatment of early seropositive rheumatoid arthritis: Doxycycline plus methotrexate versus methotrexate alone
2006
Therapeutic strategies for rheumatoid arthritis
2003
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Mast cells in the pathogenesis of rheumatic diseases and as potential targets for anti‐rheumatic therapy
2007
Sarcoidosis
2007 Standout
Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance
2002 StandoutNobel
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
Naturally Arising CD4+Regulatory T Cells for Immunologic Self -Tolerance and Negative Control of Immune Responses
2003 StandoutNobel
Induction of Tumor Immunity by Removing CD25+CD4+ T Cells: A Common Basis Between Tumor Immunity and Autoimmunity
1999 StandoutNobel
Taking regulatory T cells into medicine
2021 StandoutNobel
Immunologic Self-Tolerance Maintained by Cd25+Cd4+Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4
2000 StandoutNobel
PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice
2011 StandoutNobel
Coccolithophorid blooms in the global ocean
1994
Combination therapy versus monotherapy for the treatment of patients with rheumatoid arthritis.
2000
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Intraepithelial CD8+tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
2005 Standout
Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses
2001 StandoutNobel
Direct Expansion of Functional CD25+ CD4+ Regulatory T Cells by Antigen-processing Dendritic Cells
2003 StandoutNobel
Ocean color chlorophyll algorithms for SeaWiFS
1998 Standout
Definition of target antigens for naturally occurring CD4+ CD25+ regulatory T cells
2005 StandoutNobel
Proenkephalin+regulatory T cells expanded by ultraviolet B exposure maintain skin homeostasis with a healing function
2020 StandoutNobel
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Spectral reflectance and absorption of a massive red tide off southern California
1998
CD25+ CD4+ T Cells, Expanded with Dendritic Cells Presenting a Single Autoantigenic Peptide, Suppress Autoimmune Diabetes
2004 StandoutNobel
Antigen-bearing immature dendritic cells induce peptide-specific CD8+ regulatory T cells in vivo in humans
2002 StandoutNobel
Interleukin‐17: the missing link between T‐cell accumulation and effector cell actions in rheumatoid arthritis?
2004
Thymus and Autoimmunity: Production of CD25+CD4+ Naturally Anergic and Suppressive T Cells as a Key Function of the Thymus in Maintaining Immunologic Self-Tolerance
1999 StandoutNobel
A distinct subpopulation of CD25−T-follicular regulatory cells localizes in the germinal centers
2017 StandoutNobel
An overview of the SeaWiFS project and strategies for producing a climate research quality global ocean bio-optical time series
2004 Standout
JNK1 controls mast cell degranulation and IL-1β production in inflammatory arthritis
2010 StandoutNobel
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
2020 Standout
Education, self‐care, and outcomes of rheumatic diseases: Further challenges to the “biomedical model” paradigm
1997
T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis
2007 StandoutNobel
Works of Gerald Moore being referenced
Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: Results of a two‐year, randomized, double‐blind, placebo‐controlled trial
2002
Treatment of Rheumatoid Arthritis with Methotrexate Alone, Sulfasalazine and Hydroxychloroquine, or a Combination of All Three Medications
1996
Treatment of early seropositive rheumatoid arthritis: A two-year, double-blind comparison of minocycline and hydroxychloroquine
2001
Treatment of early seropositive rheumatoid arthritis with minocycline: Four-year followup of a double-blind, placebo-controlled trial
1999
Treatment of early Rheumatoid Arthritis with minocycline or placebo. Results of a Randomized, double‐blind, placebo‐controlled trial
1997
Prevalence of thyroid disease and abnormal thyroid function test results in patients with systemic lupus erythematosus
1987
10.1016/0967-0653(96)86690-7
2000
Efficacy of triple DMARD therapy in patients with RA with suboptimal response to methotrexate.
1996
The Atlantic Meridional Transect: overview and synthesis of data
2000
SeaWiFS Technical Report Series. Volume 29: SeaWiFS CZCS-type pigment algorithm
1995
Pigment adaptations in surface phytoplankton along the eastern boundary of the Atlantic Ocean
2004
REMOTE SENSING OF OCEANIC BIOLOGY IN RELATION TO GLOBAL CLIMATE CHANGE
1992